Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

|Videos|December 6, 2021

Practically Speaking: Driving Clinical Transformation

Author(s)Parexel

This video series discusses the impact of implementing risk-based quality management (RBQM) and decentralized clinical trials (DCTs) from the clinical operations point of view.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

A man with light hair and blue eyes stands in front of a LogiPharma background in a gray suit and white collared shirt

Improving Global Pharma Operations with Data

ByChristoph Bamert, Chief Sales Officer,ELPRO-BUCHS AG, Switzerland

June 10th 2026

Sponsored

Miranda Delatore, CoverMyMeds, on how a connected specialty access and affordability ecosystem is eliminating delays, reducing friction, and transforming the way biopharma manufacturers get patients started on life-changing therapies faster than ever before.

What Specialty Access Looks Like When It’s Built to Scale

ByMiranda Delatore, DNP, RN, NEA‑BC, CoverMyMeds

June 9th 2026

Sponsored

Two men, one with brown hair, is gesturing towards a bald man in conversation. They are both wearing Inizio Engage t-shirts.

An End-to-End Approach to Specialty Patient Services

ByJason Rains, Senior Vice President, Patient Access,Randy Quist, Vice President, Field Reimbursement,Inizio Engage

June 3rd 2026

Sponsored

Megan Wetzel and Nicole Eckl, CoverMyMeds, on navigating complex therapies and providing access and affordable treatment to patients.

What’s Next in Access & Affordability: A Biopharma Perspective

ByNicole Eckl, CoverMyMeds,Megan Wetzel, CoverMyMeds

June 2nd 2026

Sponsored

Policy Fatigue and the Future of Patient Access in Pharma

ByDane Schroeder,BGB Group

May 26th 2026

Sponsored

Trending on PharmExec

Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results

Novavax's Strategy Across Commercial, R&D, and Partnerships

Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson

FDA Approves Skinvive by Juvéderm for Improvement of Neck Appearance

Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm